Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of two agents: - **Saline** (sterile sodium chloride solution) is an inert isotonic fluid commonly used as a vehicle for intravenous drug administration, dilution, or as an intravenous fluid for hydration and electrolyte balance. - **Succinylcholine** (also known as suxamethonium) is a depolarizing neuromuscular blocker used to induce skeletal muscle relaxation during surgical procedures, facilitate tracheal intubation, and provide muscle paralysis during mechanical ventilation. Succinylcholine acts by binding to post-synaptic cholinergic receptors at the motor endplate of skeletal muscles, causing persistent depolarization and subsequent paralysis. It has rapid onset (within 60 seconds) and short duration of action (4–6 minutes). It does not affect consciousness or pain perception[1][3][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on saline + succinylcholine.